We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Intelligent Health aim to get the whole community active by providing games and incentives such as ''beat the street''. By providing schools and communities with friendly competition to walk and cycle more by tapping their cards on ''beat boxes'', and with prizes and league tables on offer, Intelligent health are bringing communities together. 
days to go: Expired investment: £700,000
Ready Burger (RB) states that it has created the UK's first scalable, value-driven, entirely plant-based Quick Service Restaurant (QSR) brand. RB claims that it has mastered the science behind the taste and texture of plant-based foods to make them indistinguishable from their non-veg counterparts. It further points out that its final products use up to 92% lesser greenhouse gases, and require up to 70% lesser water than competitor brands. RB argues that its meals cater for vegetarians, vegans, meat lovers, and people preferring Halal or Kosher foods. RB offers fast-food classics and has partnered with a global plant-based food manufacturer. RB asserts that its ergonomically designed kitchens enable it to produce 1000s of items a day, that are in turn, serviced from its central distribution centre. RB's integrated web-app ordering, in-store ordering kiosks and an innovative delivery solution allow customers to have their food in under 30 minutes. RB says it will use the investment to grow its business across different verticals.
days to go: Expired investment: £1,998,549
West Berkshire Brewery is a beer manufacturer on a mission to deliver best-in-class beers, from heritage styles to modern craft beers, to its customers. Its products are on the shelves of UK supermarkets including Waitrose, Tesco and the Co-Op. The company can scale up to 26 million pints per annum thanks to its modern brewery units that are equipped with bottling and canning lines technologies along with the option of cold storage. Its brewery consists of a 200-capacity 'Taproom & Kitchen', a destination venue that generates a revenue of £1.4 million per annum. It will utilise the investment to support the installation and commissioning of its 'Fridge Pack Machine', support marketing initiatives with its pub partners across the South of England, and provide capital to enable any pub acquisition opportunities as they arise over the coming year.

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,390,948
This award-winning French wine company are seeking funding to further expand their business. Enhancing their barrel cellar is one of their main priorities, as well as planting new vines to increase quality and replacing low yield rows of vines entirely. With the investments made, they are also planning to export to new markets.
days to go: Expired investment: £145,972
The Cheeky Panda is a manufacturer of sustainable bamboo tissue and hygiene products which are available across Europe, the Middle East and on the aisles of some of the world's top retailers including Boots, EkoPlaza, Monoprix and Carrefour. Its innovation and stress on sustainable hygiene has led to the mass-adoption of its products. The company has been rewarded with hundreds of 5-star reviews across multiple platforms including Amazon, Morrisons, and Ocado. Its proprietary Baby wipes was ranked the highest-selling new product launch of 2019 by the Grocer and Nielsen Data, and its monthly sales exceeded £500,000 for the first time in 2020 in just four years of the company's inception. Keeping in mind its drive to deliver sustainable products, the company supports the Charity patroned by Sir David Attenborough: World Land Trust. With the funds received, the company aims to channelise that into working capital to support the purchasing of ever-larger quantities of products to get sales to £20m a year and enhancing its brand identity. 

Pitch Rated

84%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £2,434,752
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph